| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.099 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |